Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Katie Macfarlane Insider Profile
4 Followers
Katie Macfarlane, Director at Pharmaust Limited, holds 263.16K shares in Pharmaust Limited (Ticker: DE:ECQ0). Most recently, Katie Macfarlane Bought €263,158 shares of Pharmaust Limited on Nov 08, 2024 for an estimated value of 50.00K.
Katie Macfarlane has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Katie Macfarlane's holdings
Insider Roles
Director
Roles that Katie Macfarlane holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Katie Macfarlane
Katie Macfarlane's Trading History
List of latest transactions for each holding click on a transaction to see Katie Macfarlane's performance on stock
You May Also Like
Katie Macfarlane insider profile FAQ
What is the percentage of profitable transactions made by Katie Macfarlane?
The percentage of profitable transactions made by Katie Macfarlane is ―.
What is the average return per transaction made by Katie Macfarlane?
The average return per transaction made by Katie Macfarlane is ―.
What stocks does Katie Macfarlane hold?
Katie Macfarlane holds: DE:ECQ0 stocks.
What was Katie Macfarlane’s latest transaction?
Katie Macfarlane latest transaction was an Informative Buy of €50.00K.
What was Katie Macfarlane's most profitable transaction?
Katie Macfarlane’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Katie Macfarlane's role in Pharmaust Limited?
Katie Macfarlane's role in Pharmaust Limited is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.